General Info

Located in Franklin, Tenn., BioMimetic Therapeutics provides a variety of medical devices and products for the repair of orthopedic, periodontal, craniofacial and sports injuries. It offers products for the treatment of bones, cartilage, ligaments and tendons, in addition to recombinant protein therapeutics with tissue-specific scaffolds and actively stimulating tissue healing and regeneration. BioMimetic Therapeutics has developed various products for the treatment of fractures and prophylactic bone augmentation, including GEM OS1, GEM OS2 and GEM 21S. The company has partnerships with Harvard Medical School, ZymoGenetics, Orthovita, Luitpold Pharmaceuticals and Chiron Corporation for manufacturing, distribution, and research and development of its products.